MedPath

Investigating the effect of education on Multiple Sclerosis patients' drug adherence

Not Applicable
Conditions
Multiple Sclerosis.
Relapsing Remitting Multiple Sclerosis
Registration Number
IRCT20210808052109N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Relapsing Remitting Multiple Sclerosis Patients
Be treated with interferon beta-1a(Rebif) at least one to four years

Exclusion Criteria

Patient dissatisfaction to continue participating in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determining the effect of education based on the theory of planned behavior on the promotion of drug adherence in patients with multiple sclerosis treated with modulatory drugs, beta 1a interferons, which are injected subcutaneously. Timepoint: Patients are first given a drug compliance questionnaire. Patients are instructed and after three months, a drug compliance questionnaire will be taken from these patients again and the effectiveness of the training will be measured. Method of measurement: To assess adherence to treatment, two questionnaires are used: 1 - Multiple Sclerosis Treatment Adherence Questionnaire 2- Theoretical questionnaire to assess the impact of the curriculum on the structures of the planned behavior theory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath